Middle East & Africa Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isother

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,550	120 Pages	The Insight Partners	January, 2024	TIP18628027

Best Price Guarantee
Price	from $3,550
Length	120 Pages
Publisher	The Insight Partners
Published Date	January, 2024
SKU	TIP18628027

Middle East & Africa Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)The Middle East & Africa molecular diagnostics market is expected to grow from US$ 825.09 million in 2022 to US$ 1,532.25 million by 2030. It is estimated to grow at a CAGR of 8.0% from 2022 to 2030.

Molecular Diagnostics in Personalized Medicine Fuels Middle East & Africa Molecular Diagnostics Market

With progress in high-throughput techniques, genome research has become more convenient and cost effective. Molecular diagnostics is becoming increasingly indispensable in clinical laboratories as these kits and tests provide rapid detection results as opposed to the conventional tests, which also involved culturing microbes in laboratory conditions in some cases. Using precision medicine, medical treatments and interventions are tailored to each patient based on their unique genetic makeup, lifestyle, and environment. Molecular diagnostics plays an important role in this approach, as it enables the identification of specific biomarkers, genetic mutations, and gene expression patterns that impact decision-making related to the treatment of patients. Drug development has become increasingly dependent on molecular diagnostics. A wide range of molecular imaging techniques are used in screening, detecting, diagnosing, treating, and assessing heterogeneity; making progression plans; examining molecular characteristics; and monitoring patient outcomes. In addition, molecular imaging can aid in the detection of tiny tumors and assessment of their activities, contributing significantly to the development and expansion of personalized medicine, research, clinical trials, and medical practice in oncology. A high-throughput genotyping platform can be used to detect genetic aberrations in clinical samples, and next-generation sequencing can be used to identify all types of cancer-causing changes. The introduction of these techniques into clinical practice would enable the identification of molecular targets in each patient, along with facilitating the tracking of the molecular progression of diseases. With these approaches, cancer patients will be able to receive personalized medicine. Thus, with technology ever evolving, the market for molecular diagnostics seems to have a bright future.

Middle East & Africa Molecular Diagnostics Market Overview

The UAE, Saudi Arabia, and South Africa are major countries in the Middle East & Africa. Saudi Arabia held the largest share of the regional molecular diagnostics market in 2022. The market in the Middle East & Africa is anticipated to grow during 2022–2030 due to the rising prevalence of various chronic diseases such as cardiovascular diseases, diabetes, gastrointestinal diseases, and respiratory diseases and increasing government initiatives in terms of funding and healthcare-related policies.

Middle East & Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Molecular Diagnostics Market Segmentation

The Middle East & Africa molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the Middle East & Africa molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest Middle East & Africa molecular diagnostics market share in 2022.

Based on technology, the Middle East & Africa molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest Middle East & Africa molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the Middle East & Africa molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest Middle East & Africa molecular diagnostics market share in 2022.

Based on end users, the Middle East & Africa molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest Middle East & Africa molecular diagnostics market share in 2022.

Based on country, the Middle East & Africa molecular diagnostics market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa molecular diagnostics market in 2022.

Abbott Laboratories, bioMerieux SA, Danaher, F. Hoffmann-La Roche Ltd, Illumina Inc, Novartis AG, Qiagen NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Middle East & Africa molecular diagnostics market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa molecular diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the molecular diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction: 1.1 The Insight Partners Research Report Guidance; 1.2 Market Segmentation
2. Executive Summary: 2.1 Key Insights
3. Research Methodology: 3.1 Coverage; 3.2 Secondary Research; 3.3 Primary Research
4. Middle East & Africa Molecular Diagnostics Market Landscape: 4.1 Overview; 4.2 PEST Analysis; 4.2.1 Middle East & Africa PEST Analysis
5. Middle East & Africa Molecular Diagnostics Market - Key Industry Dynamics: 5.1 Key Market Drivers:; 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing; 5.1.2 Surging Prevalence of Associated Diseases; 5.2 Market Restraints; 5.2.1 Limitations Associated with Molecular Testing; 5.3 Market Opportunities; 5.3.1 Advancements in Molecular Diagnostics Technologies; 5.4 Future Trends; 5.4.1 Molecular Diagnostics in Personalized Medicine; 5.5 Impact Analysis:
6. Molecular Diagnostics Market - Middle East & Africa Market Analysis: 6.1 Middle East & Africa Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Disease Area: 7.1 Overview; 7.2 Middle East & Africa Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%); 7.3 Oncology; 7.3.1 Overview; 7.3.2 Oncology: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.4 Infectious Disease; 7.4.1 Overview; 7.4.2 Infectious Disease: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.5 Genetic Testing; 7.5.1 Overview; 7.5.2 Genetic Testing: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.6 Cardiac Diseases; 7.6.1 Overview; 7.6.2 Cardiac Diseases: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.7 Immune System Disorders; 7.7.1 Overview; 7.7.2 Immune System Disorders: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 7.8 Others; 7.8.1 Overview; 7.8.2 Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Technology: 8.1 Overview; 8.2 Middle East & Africa Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%); 8.3 Polymerase Chain Reaction; 8.3.1 Overview; 8.3.2 PCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.3.2.1 RT-PCR; 8.3.2.1.1 Overview; 8.3.3 RT-PCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.3.3.1 qPCR; 8.3.3.1.1 Overview; 8.3.4 qPCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.3.4.1 Multiplex PCR; 8.3.4.1.1 Overview; 8.3.5 Multiplex PCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.3.5.1 Others; 8.3.5.1.1 Overview; 8.3.6 Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT); 8.4.1 Overview; 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.5 DNA Sequencing and Next-Generation Sequencing (NGS); 8.5.1 Overview; 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.6 DNA Microarrays; 8.6.1 Overview; 8.6.2 DNA Microarrays: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.7 In-Situ Hybridization (ISH); 8.7.1 Overview; 8.7.2 In-Situ Hybridization (ISH): Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 8.8 Others; 8.8.1 Overview; 8.8.2 Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services: 9.1 Overview; 9.2 Middle East & Africa Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%); 9.3 Assays and Kits; 9.3.1 Overview; 9.3.2 Assays and Kits: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 9.4 Instruments; 9.4.1 Overview; 9.4.2 Instruments: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 9.5 Services and Software; 9.5.1 Overview; 9.5.2 Services and Software: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 – by End User: 10.1 Overview; 10.2 Middle East & Africa Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%); 10.3 Hospitals and Clinics; 10.3.1 Overview; 10.3.2 Hospitals and Clinics: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 10.4 Diagnostics Laboratories; 10.4.1 Overview; 10.4.2 Diagnostics Laboratories: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 10.5 Research and Academic Institutes; 10.5.1 Overview; 10.5.2 Research and Academic Institutes: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); 10.6 Others; 10.6.1 Overview; 10.6.2 Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Molecular Diagnostics Market - Country Analysis: 11.1 Middle East & Africa Molecular Diagnostics Market, Revenue and Forecast to 2030; 11.1.1 Overview; 11.1.1.1 Middle East & Africa Molecular Diagnostics Market by Country; 11.1.2 UAE; 11.1.2.1 Overview; 11.1.3 UAE: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.4 UAE: Molecular Diagnostics Market, by Disease Area; 11.1.5 UAE: Molecular Diagnostics Market, by Technology; 11.1.5.1 UAE: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.6 UAE: Molecular Diagnostics Market, by Product and Services; 11.1.7 UAE: Molecular Diagnostics Market, by End User; 11.1.8 Saudi Arabia; 11.1.8.1 Overview; 11.1.9 Saudi Arabia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.10 Saudi Arabia: Molecular Diagnostics Market, by Disease Area; 11.1.11 Saudi Arabia: Molecular Diagnostics Market, by Technology; 11.1.11.1 Saudi Arabia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.12 Saudi Arabia: Molecular Diagnostics Market, by Product and Services; 11.1.13 Saudi Arabia: Molecular Diagnostics Market, by End User; 11.1.14 South Africa; 11.1.14.1 Overview; 11.1.15 South Africa: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.16 South Africa: Molecular Diagnostics Market, by Disease Area; 11.1.17 South Africa: Molecular Diagnostics Market, by Technology; 11.1.17.1 South Africa: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.18 South Africa: Molecular Diagnostics Market, by Product and Services; 11.1.19 South Africa: Molecular Diagnostics Market, by End User; 11.1.20 Rest of Middle East & Africa; 11.1.20.1 Overview; 11.1.21 Rest of Middle East & Africa: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); 11.1.22 Rest of Middle East & Africa: Molecular Diagnostics Market, by Disease Area; 11.1.23 Rest of Middle East & Africa: Molecular Diagnostics Market, by Technology; 11.1.23.1 Rest of Middle East & Africa: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR); 11.1.24 Rest of Middle East & Africa: Molecular Diagnostics Market, by Product and Services; 11.1.25 Rest of Middle East & Africa: Molecular Diagnostics Market, by End User
12. Middle East & Africa Molecular Diagnostics Market Industry Landscape: 12.1 Overview; 12.2 Growth Strategies Done by the Companies in the Market (%); 12.3 Organic Developments; 12.3.1 Overview; 12.4 Inorganic Developments; 12.4.1 Overview
13. Middle East & Africa Molecular Diagnostics Market, Key Company Profiles: 13.1 Abbott Laboratories; 13.1.1 Key Facts; 13.1.2 Business Description; 13.1.3 Products and Services; 13.1.4 Financial Overview; 13.1.5 SWOT Analysis; 13.1.6 Key Developments; 13.2 Thermo Fisher Scientific Inc; 13.2.1 Key Facts; 13.2.2 Business Description; 13.2.3 Products and Services; 13.2.4 Financial Overview; 13.2.5 SWOT Analysis; 13.2.6 Key Developments; 13.3 F. Hoffmann-La Roche Ltd; 13.3.1 Key Facts; 13.3.2 Business Description; 13.3.3 Products and Services; 13.3.4 Financial Overview; 13.3.5 SWOT Analysis; 13.3.6 Key Developments; 13.4 Qiagen NV; 13.4.1 Key Facts; 13.4.2 Business Description; 13.4.3 Products and Services; 13.4.4 Financial Overview; 13.4.5 SWOT Analysis; 13.4.6 Key Developments; 13.5 bioMerieux SA; 13.5.1 Key Facts; 13.5.2 Business Description; 13.5.3 Products and Services; 13.5.4 Financial Overview; 13.5.5 SWOT Analysis; 13.5.6 Key Developments; 13.6 Illumina Inc; 13.6.1 Key Facts; 13.6.2 Business Description; 13.6.3 Products and Services; 13.6.4 Financial Overview; 13.6.5 SWOT Analysis; 13.6.6 Key Developments; 13.7 Danaher; 13.7.1 Key Facts; 13.7.2 Business Description; 13.7.3 Products and Services; 13.7.4 Financial Overview; 13.7.5 SWOT Analysis; 13.7.6 Key Developments; 13.8 Siemens Healthineers AG; 13.8.1 Key Facts; 13.8.2 Business Description; 13.8.3 Products and Services; 13.8.4 Financial Overview; 13.8.5 SWOT Analysis; 13.8.6 Key Developments; 13.9 Novartis AG; 13.9.1 Key Facts; 13.9.2 Business Description; 13.9.3 Products and Services; 13.9.4 Financial Overview; 13.9.5 SWOT Analysis; 13.9.6 Key Developments
14. Appendix: 14.1 About Us; 14.2 Glossary of Terms
LIST OF TABLES: Table 1. Middle East & Africa Molecular Diagnostics Market Segmentation; Table 2. UAE: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 3. UAE: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 4. UAE: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 5. UAE: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 6. UAE: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 7. Saudi Arabia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 8. Saudi Arabia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 9. Saudi Arabia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 10. Saudi Arabia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 11. Saudi Arabia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 12. South Africa: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 13. South Africa: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 14. South Africa: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 15. South Africa: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 16. South Africa: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 17. Rest of Middle East & Africa: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area; Table 18. Rest of Middle East & Africa: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology; Table 19. Rest of Middle East & Africa: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR); Table 20. Rest of Middle East & Africa: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services; Table 21. Rest of Middle East & Africa: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User; Table 22. Organic Developments Done By Companies; Table 23. Inorganic Developments Done By Companies; Table 24. Glossary of Terms, Molecular Diagnostics Market
LIST OF FIGURES: Figure 1. Middle East & Africa - PEST Analysis; Figure 2. Middle East & Africa Molecular Diagnostics Market - Key Industry Dynamics; Figure 3. Impact Analysis of Drivers and Restraints; Figure 4. Middle East & Africa Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030; Figure 5. Middle East & Africa Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%); Figure 6. Oncology: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 7. Infectious Disease: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 8. Genetic Testing: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 9. Cardiac Diseases: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 10. Immune System Disorders: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 11. Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 12. Middle East & Africa Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%); Figure 13. PCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 14. RT-PCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 15. qPCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 16. Multiplex PCR: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 17. Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 20. DNA microarrays: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 21. In-Situ Hybridization (ISH): Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 22. Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 23. Middle East & Africa Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%); Figure 24. Assays and Kits: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 25. Instruments: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 26. Services and Software: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 27. Middle East & Africa Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%); Figure 28. Hospitals and Clinics: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 29. Ambulatory Surgical Centers: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 30. Research and Academic Institutes: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 31. Others: Middle East & Africa Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million); Figure 32. Molecular Diagnostics Market, By Country, 2022 And 2030 ($Mn); Figure 33. Middle East & Africa Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%); Figure 34. UAE: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn); Figure 35. Saudi Arabia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn); Figure 36. South Africa: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn); Figure 37. Rest of Middle East & Africa: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn); Figure 38. Growth Strategies Done by the Companies in the Market (%)